Search results
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowen
ETF DAILY NEWS· 3 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lifted by TD Cowen from $1,020.00 to $1,030.00 in a research report issued ...
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoCwm LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 4th quarter, according to its most recent disclosure ...
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: Danaher Corp. DHR,Regeneron Pharmaceuticals, Inc....
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
WSAU Wausau· 4 days ago(Reuters) - Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop...
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 4 days agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Mammoth Biosciences to Receive $100M Upfront in Therapeutic CRISPR Gene Editing Deal With Regeneron
GenomeWeb News· 4 days agoRegeneron Pharmaceuticals said Thursday that it will collaborate with Mammoth Biosciences on the research, development, and commercialization of therapies ...
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Zacks via Yahoo Finance· 5 days agoToday's Research Daily features new research reports on 16 major stocks, including Danaher...
11 Oversold Growth Stocks to Buy Right Now
Insider Monkey via Yahoo Finance· 11 hours agoIn this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip our analysis of the recent trends and market activity,...
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: Regeneron Pharmaceuticals is upping its investment in genetic medicine, announcing Thursday a $100 million deal with CRISPR drug developer...
Regeneron Pharmaceuticals, Inc. [NASDAQ: REGN] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 3 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regeneron Pharmaceuticals, ...